XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Debt - Additional Information (Details) - USD ($)
3 Months Ended
Mar. 14, 2022
Mar. 04, 2022
Mar. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]        
Cash and cash equivalents     $ 20,800,384 $ 12,710,762
Proceeds allocated to SWK Warrant     327,031  
Debt issuance costs incurred     1,200,000  
SWK Warrant        
Debt Instrument [Line Items]        
Fair value of warrant     300,000  
Bridge Loan        
Debt Instrument [Line Items]        
Fair value of loan     6,200,000  
Financial Advisor        
Debt Instrument [Line Items]        
Debt issuance costs incurred     700,000  
SWK and Holders        
Debt Instrument [Line Items]        
Debt issuance costs incurred     500,000  
Term Loan | Financial Advisor        
Debt Instrument [Line Items]        
Payment for funding fee for services     700,000  
Bridge Loan and Convertible Note Financing | Financial Advisor        
Debt Instrument [Line Items]        
Payment for funding fee for services     500,000  
SWK Credit Agreement | Lenders Party and SWK        
Debt Instrument [Line Items]        
Cash and cash equivalents     2,000,000.0  
SWK Credit Agreement | Bridge Loan        
Debt Instrument [Line Items]        
Principal amortization payments     $ 1,300,000  
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK        
Debt Instrument [Line Items]        
Debt instrument, principal amount   $ 6,500,000    
Debt instrument, interest rate     12.00%  
Debt instrument, interest rate, increase   3.00%    
Debt instrument, maturity date, description     The final maturity date of the Bridge Loan is (a) if full approval by FDA for marketing of the Company’s product known as ACER-001 (sodium phenylbutyrate) (“ACER-001 Approval”) occurs on or before September 30, 2022, then the date which is 12 business days after ACER-001 Approval, or (b) if ACER-001 Approval does not occur on or before September 30, 2022, then March 4, 2024.  
Cash and cash equivalents     $ 1,500,000  
Origination fees $ 100,000      
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | SWK Warrant        
Debt Instrument [Line Items]        
Warrant issued to purchase common stock   150,000    
Warrant, exercise price   $ 2.46    
Proceeds allocated to SWK Warrant   $ 300,000    
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | Minimum [Member]        
Debt Instrument [Line Items]        
Cash and cash equivalents     $ 4,000,000.0  
Number of days required for cash balance     20 days  
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | Maximum        
Debt Instrument [Line Items]        
Cash and cash equivalents     $ 6,500,000  
Number of days required for cash balance     40 days  
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | If ACER-001 Approval does not Occur on or Before September 30, 2022        
Debt Instrument [Line Items]        
Debt instrument, maturity date   Mar. 04, 2024    
Debt instrument repayment percentage on outstanding principal plus any and all paid-in-kind interest amount   150.00%    
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | If ACER-001 Approval Occur on or Before September 30, 2022        
Debt Instrument [Line Items]        
Debt instrument repayment percentage on outstanding principal plus any and all paid-in-kind interest amount   130.00%    
SWK Credit Agreement | Bridge Loan | Lenders Party and SWK | LIBOR        
Debt Instrument [Line Items]        
Debt instrument, description of variable rate basis     3-month LIBOR  
Debt instrument, interest rate   1.00%    
Debt instrument, basis spread on variable rate   11.00%    
Debt instrument, periodic payment, principal   $ 700,000    
Debt instrument, frequency of periodic payment     quarterly  
Loan repayment commencing date   Nov. 15, 2022    
Secured Convertible Note Purchase Agreement | Secured Convertible Notes | MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P.        
Debt Instrument [Line Items]        
Debt instrument, principal amount   $ 6,000,000.0    
Debt instrument, interest rate   6.50%    
Debt instrument, interest rate, increase   11.50%    
Debt instrument, frequency of periodic payment     quarterly  
Conversion price   $ 2.50    
Marathon Credit Agreement | Term Loan | Lender Party and Marathon        
Debt Instrument [Line Items]        
Debt instrument, principal amount   $ 42,500,000    
Debt instrument, interest rate   13.50%    
Debt instrument, frequency of periodic payment     quarterly  
Debt instrument, maturity date, description     The final maturity date of the Term Loan is the earlier of six years after the Term Loan Funding Date or December 31, 2028.  
Debt instrument, maturity date   Dec. 31, 2028    
Commitment fee percentage on term loan amount   1.50%    
Line of credit facility, maximum borrowing capacity   $ 92,500,000    
Line of credit facility, additional borrowing capacity   $ 50,000,000.0    
Percentage of option to capitalize 4.00%      
Debt instrument amortization percentage   2.78%    
Percentage of prepayment, prior to March 4, 2025   5.00%    
Percentage of prepayment, on or after March 4, 2025, but prior to March 4, 2026   3.00%    
Percentage of prepayment, on or after March 4, 2026, but prior to March 4, 2027   2.00%    
Percentage of prepayment, on or after March 4, 2027   1.00%    
Payment for commitment fees   $ 200,000    
Payment for additional commitment fees   $ 600,000    
Percentage of aggregate revenue as royalty payments   2.00%    
Royalty payments on aggregate revenue cap amount   $ 15,000,000.0    
Additional capitalized commitment fee   $ 200,000